nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study
|
Lao, Minxi |
|
|
38 |
2 |
p. 535-543 |
artikel |
2 |
Active tuberculosis in patients with systemic lupus erythematosus from Southern China: a retrospective study
|
Lao, Minxi |
|
2018 |
38 |
2 |
p. 535-543 |
artikel |
3 |
Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements
|
Žigon, Polona |
|
2018 |
38 |
2 |
p. 371-378 |
artikel |
4 |
Adverse drug events associated with 5mg versus 10mg Tofacitinib (Janus kinase inhibitor) twice daily for the treatment of autoimmune diseases: A systematic review and meta-analysis of randomized controlled trials
|
Huang, Feng |
|
2018 |
38 |
2 |
p. 523-534 |
artikel |
5 |
Antiphospholipid antibodies in adult IgA vasculitis: observational study
|
Hočevar, Alojzija |
|
2018 |
38 |
2 |
p. 347-351 |
artikel |
6 |
Association between primary Sjogren’s syndrome, arterial stiffness, and subclinical atherosclerosis: a systematic review and meta-analysis
|
Yong, Wai Chung |
|
2018 |
38 |
2 |
p. 447-455 |
artikel |
7 |
Association between the BANK1 rs3733197 polymorphism and polymyositis/dermatomyositis in a Chinese Han population
|
Chen, Si |
|
2018 |
38 |
2 |
p. 431-436 |
artikel |
8 |
Autoantibodies against dsDNA measured with nonradioactive Farr assay—an alternative for routine laboratories
|
Lakota, K. |
|
2018 |
38 |
2 |
p. 353-359 |
artikel |
9 |
Clinically important neutralizing anti-drug antibodies detected with an in-house competitive ELISA
|
Ogrič, Manca |
|
2018 |
38 |
2 |
p. 361-370 |
artikel |
10 |
Clinical role of albumin to globulin ratio in microscopic polyangiitis: a retrospective monocentric study
|
Ahn, Sung Soo |
|
2018 |
38 |
2 |
p. 487-494 |
artikel |
11 |
Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients
|
Fabiani, Claudia |
|
2018 |
38 |
2 |
p. 407-415 |
artikel |
12 |
Correction to: the efficacy and safety of total glucosides of peony in the treatment of primary Sjögren’s syndrome: a multi-center, randomized, double-blinded, placebo-controlled clinical trial
|
Liu, Xia |
|
2018 |
38 |
2 |
p. 617-618 |
artikel |
13 |
Correlation between magnetic resonance imaging (MRI) findings and the new bone formation factor Dkk-1 in patients with spondyloarthritis
|
Zhao, Zheng |
|
2018 |
38 |
2 |
p. 465-475 |
artikel |
14 |
Detection of a novel mutation in NLRP3/CIAS1 gene in an Indian child with Neonatal-Onset Multisystem Inflammatory Disease (NOMID)
|
Nair, Sona B. |
|
2018 |
38 |
2 |
p. 403-406 |
artikel |
15 |
Determination of the minimally important difference (MID) in multi-biomarker disease activity (MBDA) test scores: impact of diurnal and daily biomarker variation patterns on MBDA scores
|
Chernoff, David |
|
2018 |
38 |
2 |
p. 437-445 |
artikel |
16 |
Does leflunomide have a role in giant cell arteritis? An open-label study
|
Hočevar, Alojzija |
|
2018 |
38 |
2 |
p. 291-296 |
artikel |
17 |
Efficacy and tolerance of anakinra in acute calcium pyrophosphate crystal arthritis: a retrospective study of 33 cases
|
Thomas, Marion |
|
2018 |
38 |
2 |
p. 425-430 |
artikel |
18 |
Efficacy of new treatments for dactylitis of psoriatic arthritis: update of literature review
|
Sondag, Maxime |
|
2018 |
38 |
2 |
p. 591-596 |
artikel |
19 |
Endothelial dysfunction in patients with eosinophilic granulomatosis with polyangiitis
|
Pacholczak, Renata |
|
2018 |
38 |
2 |
p. 417-424 |
artikel |
20 |
Gender differences in patients with fibromyalgia: a gait analysis
|
Heredia-Jimenez, Jose |
|
2018 |
38 |
2 |
p. 513-522 |
artikel |
21 |
Gene and miRNA expression in giant cell arteritis—a concise systematic review of significantly modified studies
|
Kuret, Tadeja |
|
2018 |
38 |
2 |
p. 307-316 |
artikel |
22 |
Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium
|
Muilu, Paula |
|
2018 |
38 |
2 |
p. 555-562 |
artikel |
23 |
Insight into inflammatory cell and cytokine profiles in adult IgA vasculitis
|
Kuret, T. |
|
2018 |
38 |
2 |
p. 331-338 |
artikel |
24 |
It is time for an organised, scientific approach to the application of patient-reported outcome measures in clinical studies and trials
|
McKenna, Stephen P. |
|
2018 |
38 |
2 |
p. 611-615 |
artikel |
25 |
Juvenile arthritis management in less resourced countries (JAMLess): consensus recommendations from the Cradle of Humankind
|
Scott, Christiaan |
|
2018 |
38 |
2 |
p. 563-575 |
artikel |
26 |
Letter to editor: New onset/recurrence of inflammatory arthralgia/spondyloarthritis in patients treated with vedolizumab for intestinal bowel disease
|
Tamanini, Silvia |
|
2018 |
38 |
2 |
p. 609-610 |
artikel |
27 |
Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab
|
Baker, Rahaf |
|
2018 |
38 |
2 |
p. 603-608 |
artikel |
28 |
Macrophage activation syndrome in a patient with axial spondyloarthritis on adalimumab
|
Baker, Rahaf |
|
|
38 |
2 |
p. 603-608 |
artikel |
29 |
MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet’s disease patients
|
Ibrahim, W |
|
2018 |
38 |
2 |
p. 397-402 |
artikel |
30 |
MicroRNA expression in the affected skin of adult patients with IgA vasculitis
|
Hočevar, Alojzija |
|
2018 |
38 |
2 |
p. 339-345 |
artikel |
31 |
Mycophenolate mofetil treatment with or without a calcineurin inhibitor in resistant inflammatory myopathy
|
Hanaoka, Hironari |
|
2018 |
38 |
2 |
p. 585-590 |
artikel |
32 |
On demand use of anakinra for attacks of familial Mediterranean fever (FMF)
|
Babaoglu, Hakan |
|
2018 |
38 |
2 |
p. 577-581 |
artikel |
33 |
Osteoarthritis: a call for research on central pain mechanism and personalized prevention strategies
|
Villafañe, Jorge Hugo |
|
2018 |
38 |
2 |
p. 583-584 |
artikel |
34 |
Osteoporosis: a clinical and pharmacological update
|
Vidal, Maritza |
|
2018 |
38 |
2 |
p. 385-395 |
artikel |
35 |
Prevalence and frequency of self-perceived systemic features in people with joint hypermobility syndrome/Ehlers-Danlos syndrome hypermobility type
|
Chan, Cliffton |
|
2018 |
38 |
2 |
p. 503-511 |
artikel |
36 |
Prolonged remission is associated with a reduced risk of cardiovascular disease in patients with systemic lupus erythematosus: a GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study
|
Fasano, Serena |
|
2018 |
38 |
2 |
p. 457-463 |
artikel |
37 |
Red blood cell distribution width as a potential predictor of survival of pulmonary arterial hypertension associated with primary Sjogren’s syndrome: a retrospective cohort study
|
Hui, Min |
|
2018 |
38 |
2 |
p. 477-485 |
artikel |
38 |
Rheumatology in and from Slovenia
|
Adebajo, Ade |
|
2018 |
38 |
2 |
p. 271 |
artikel |
39 |
Serum interleukin-37 level and interleukin-37 gene polymorphism in patients with Behçet disease
|
Özgüçlü, Selcan |
|
2018 |
38 |
2 |
p. 495-502 |
artikel |
40 |
Severe necrotizing myositis associated with long term anti-neoplastic efficacy following nivolumab plus ipilimumab combination therapy
|
Tauber, Marie |
|
2018 |
38 |
2 |
p. 601-602 |
artikel |
41 |
Stroke and antiphospholipid syndrome—antiphospholipid antibodies are a risk factor for an ischemic cerebrovascular event
|
Gašperšič, Nataša |
|
2018 |
38 |
2 |
p. 379-384 |
artikel |
42 |
Study of clinical utility of antibodies to phosphatidylserine/prothrombin complex in Asian-Indian patients with suspected APS
|
Ganapati, Arvind |
|
2018 |
38 |
2 |
p. 545-553 |
artikel |
43 |
The impact of obesity on SLE disease activity: findings from the Southern California Lupus Registry (SCOLR)
|
Teh, Phildrich |
|
2018 |
38 |
2 |
p. 597-600 |
artikel |
44 |
The incidence of giant cell arteritis in Slovenia
|
Pucelj, Nataša Potočnik |
|
2018 |
38 |
2 |
p. 285-290 |
artikel |
45 |
The incidence of idiopathic inflammatory myopathies in the adult Slovenian population
|
Ostrovršnik, Jaka |
|
2018 |
38 |
2 |
p. 279-283 |
artikel |
46 |
The incidence rate and the early management of rheumatoid arthritis in Slovenia
|
Ješe, Rok |
|
2018 |
38 |
2 |
p. 273-278 |
artikel |
47 |
The persistence of golimumab compared to other tumour necrosis factor-α inhibitors in daily clinical practice for the treatment of rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: observations from the Slovenian nation-wide longitudinal registry of patients treated with biologic disease-modifying antirheumatic drugs—BioRx.si
|
Rotar, Žiga |
|
2018 |
38 |
2 |
p. 297-305 |
artikel |
48 |
Utility of serological biomarkers for giant cell arteritis in a large cohort of treatment-naïve patients
|
Burja, Blaž |
|
2018 |
38 |
2 |
p. 317-329 |
artikel |